Pharmaceuticals, Biotechnology and Life Sciences
REDWOOD CITY, Calif., April 21, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel…
First patient dosed in ReSPECT-LM Phase 1/2a dose escalation trial of 186RNL for leptomeningeal metastases Closed in-licensing transaction for novel…
JERSEY CITY, N.J., April 21, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced that it has commenced an…
Ameluz® for the treatment of actinic keratoses now at www.ameluz.comXepi® for the treatment of impetigo now at www.xepicream.com WOBURN, Mass. ,…
Q1 2022 sales Business growth Sales Increase of 2.7% compared with Q1 2021 (€181.1m)Up 0.5% at constant exchange rates (CER1)…
LA JOLLA, Calif., April 20, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
– Engineered exosome vaccine construct generated durable, comprehensive immunity in vivo – CAMBRIDGE, Mass., April 20, 2022 (GLOBE NEWSWIRE) —…
Laura Clague to step-down as CFO in August 2022 and retire in 2023 Chris Cline, Travere SVP of Investor Relations…
Company announcement – No. 14 / 2022 Zealand Pharma launches long-term incentive program for Zealand’s Board of Directors for 2022 Copenhagen,…
Lille, France; Cambridge, MA; April 20, 2022 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…